Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 206 | 256 | 98 | 120 | 168 |
| Cost of Goods | 283 | 32 | 11 | 107 | 14 |
| Gross Profit | -77 | 224 | 87 | 13 | 154 |
| Operating Expenses | 10,429 | 10,538 | 14,326 | 15,972 | 10,267 |
| Operating Income | -10,223 | -10,282 | -14,228 | -15,852 | -10,099 |
| Interest Expense | 4,198 | 4,396 | 4,373 | 4,222 | 3,993 |
| Other Income | 1,730 | 2,133 | -12,310 | 887 | 6,838 |
| Pre-tax Income | -12,691 | -12,545 | -30,911 | -19,187 | -7,254 |
| Net Income Continuous | -12,691 | -12,545 | -30,911 | -19,187 | -7,254 |
| Net Income | $-12,691 | $-12,545 | $-30,911 | $-19,187 | $-7,254 |
| EPS Basic Total Ops | -0.54 | 0.40 | -2.18 | -2.45 | -1.50 |
| EPS Basic Continuous Ops | -0.54 | 0.40 | -2.18 | -2.45 | -1.50 |
| EPS Diluted Total Ops | -0.54 | 0.40 | -2.18 | -2.45 | -1.50 |
| EPS Diluted Continuous Ops | -0.54 | 0.40 | -2.18 | -2.45 | -1.50 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.58 | -2.18 | -2.45 | -1.50 |
| EBITDA(a) | $-10,165 | $-10,208 | $-14,153 | $-15,777 | $-10,023 |